🏛️ Verified NIH Record • Updated 2025-09-02
OCS DCD Heart + CAP Continued Follow-Up (NCT05741723)
OCS DCD Heart + CAP Continued Follow-Up Post-Approval Study
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: TransMedics
🩺 Plain-English Summary (8th-Grade Level)
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Who can join: Review the eligibility criteria below.
Location: University of California San Diago — La Jolla, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (20 Sites)
- University of California San Diago — La Jolla, California
- Stanford University — Palo Alto, California
- Yale New Haven Hospital — New Haven, Connecticut
- Mayo Clinic Florida — Jacksonville, Florida
- AdventHealth Orlando — Orlando, Florida
- Emory University Hospital — Atlanta, Georgia
- Northwestern Medicine — Chicago, Illinois
- St. Vincent Cardiovascular Research Institute — Indianapolis, Indiana
- Tufts Medical Center — Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts
- Minneapolis Heart Institute — Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota
- University of Nebraska Medical Center — Omaha, Nebraska
- Nyph/Cumc — New York, New York
- Montefiore — The Bronx, New York
- Duke University — Durham, North Carolina
- Vanderbilt Medical Center — Nashville, Tennessee
- Sentara — Norfolk, Virginia
- University of Wisconsin — Madison, Wisconsin
- Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Transplant
- XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP) — La Jolla, California
- US National OCS Heart Perfusion (OHP) Registry — Phoenix, Arizona
- Randomized Trial of SGLT2i in Heart Transplant Recipients — Palo Alto, California
- Belatacept in Heart Transplantation — Los Angeles, California
- Non-invasive Prediction of EArly Cardiac rEjection — Little Rock, Arkansas
Explore by condition: All Heart Transplant clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.